Reported 19,136 shares, up 12,512 (188.9%) from the prior quarter.
Reported value 160.0%; share count 188.9% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 135000 |
| 2022-03-31 | 90000 |
| 2022-06-30 | 234000 |
| 2022-09-30 | 2887000 |
| 2022-12-31 | 3909027 |
| 2023-03-31 | 19961849 |
| 2023-06-30 | 16868745 |
| 2023-09-30 | 9867036 |
| 2023-12-31 | 4730113 |
| 2024-03-31 | 7338861 |
| 2024-06-30 | 1457095 |
| 2024-09-30 | 725237 |
| 2024-12-31 | 5498818 |
| 2025-03-31 | 1007583 |
| 2025-06-30 | 1114979 |
| 2025-09-30 | 758084 |
| 2025-12-31 | 38765348 |
| 2026-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2026 | Reduced | 0 | -4,292,951 (-100.0%) | 0 | $0 | 2026-05-15 | |
| Q4 2025 | Added | 4,292,951 | +4,049,194 (1661.2%) | < 0.01% | $38,765,348 | 2026-02-13 | |
| Q3 2025 | Reduced | 243,757 | -277,261 (-53.2%) | < 0.01% | $758,084 | 2025-11-14 | |
| Q2 2025 | Reduced | 521,018 | -355,142 (-40.5%) | < 0.01% | $1,114,979 | 2025-08-15 | |
| Q1 2025 | Reduced | 876,160 | -1,634,716 (-65.1%) | < 0.01% | $1,007,583 | 2025-05-15 | |
| Q4 2024 | Added | 2,510,876 | +2,178,199 (654.7%) | < 0.01% | $5,498,818 | 2025-02-14 | |
| Q3 2024 | Reduced | 332,677 | -298,100 (-47.3%) | < 0.01% | $725,237 | 2024-11-14 | |
| Q2 2024 | Reduced | 630,777 | -703,561 (-52.7%) | < 0.01% | $1,457,095 | 2024-08-14 | |
| Q1 2024 | Reduced | 1,334,338 | -580,688 (-30.3%) | < 0.01% | $7,338,861 | 2024-05-15 | |
| Q4 2023 | Added | 1,915,026 | +1,630,919 (574.1%) | < 0.01% | $4,730,113 | 2024-02-13 | |
| Q3 2023 | Reduced | 284,107 | -230,184 (-44.8%) | < 0.01% | $9,867,036 | 2023-11-15 | |
| Q2 2023 | Reduced | 514,291 | -81,585 (-13.7%) | < 0.01% | $16,868,745 | 2023-08-14 | |
| Q1 2023 | Added | 595,876 | +476,662 (399.8%) | < 0.01% | $19,961,849 | 2023-05-15 | |
| Q4 2022 | Added | 119,214 | +36,464 (44.1%) | < 0.01% | $3,909,027 | 2023-02-14 | |
| Q3 2022 | Added | 82,750 | +63,614 (332.4%) | < 0.01% | $2,887,000 | 2022-11-14 | |
| Q2 2022 | Added | 19,136 | +12,512 (188.9%) | < 0.01% | $234,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 6,624 | -162 (-2.4%) | < 0.01% | $90,000 | 2022-05-13 | |
| Q4 2021 | New | 6,786 | +6,786 (0.0%) | < 0.01% | $135,000 | 2022-02-14 |
Who else reported the position
66 managers reported VENTYX BIOSCIENCES INC for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| venBio Partners LLC | Unchanged | 5,011,536 | 0 | 17.45% | $61,291,000 | 3 qtrs |
| Third Point LLC | Unchanged | 4,312,834 | 0 | 1.25% | $52,746,000 | 3 qtrs |
| CITADEL ADVISORS LLC | Reduced | 3,891,328 | -20,582 | 0.01% | $47,591,000 | 3 qtrs |
| Logos Global Management LP | Reduced | 2,312,680 | -201,600 | 5.19% | $28,284,000 | 3 qtrs |
| Vivo Capital LLC | Unchanged | 1,921,726 | 0 | 2.36% | $23,503,000 | 3 qtrs |
| JANUS HENDERSON GROUP PLC | Reduced | 1,905,247 | -228,607 | 0.02% | $23,296,000 | 3 qtrs |
| FMR LLC | Added | 1,575,942 | +758,903 | < 0.01% | $19,273,771 | 3 qtrs |
| RTW INVESTMENTS LP | Unchanged | 1,551,778 | 0 | 0.49% | $18,978,000 | 3 qtrs |
| EcoR1 Capital LLC | Unchanged | 1,300,000 | 0 | 0.55% | $15,899,000 | 3 qtrs |
| ORBIMED ADVISORS LLC | Unchanged | 1,289,280 | 0 | 0.29% | $15,768,000 | 3 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 15, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 18,996
- Shared
- 0
- None
- 140
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.